Metraipolis › archive › dc_66dbc29d99cc

A Pilot Study of Salmon Protein Hydrolysate (ProGo®) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health — Europe PMC PMID:42652046

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42652046
DOI
10.3390/biomedicines14081663
License (as archived)
solo-consultazione
Archived
2026-10-17T19:57:07.361Z
SHA-256 of the archived text
8d86275b427f2b4c809f64e230e66084da4cde922e23485edd00e7d0b4531161
Stable URL of this page
https://metraipolis.com/documento/dc_66dbc29d99cc

How to cite

A Pilot Study of Salmon Protein Hydrolysate (ProGo®) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health — Europe PMC PMID:42652046 — Europe PMC (en), https://europepmc.org/article/MED/42652046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_66dbc29d99cc (Metraipolis archive dc_66dbc29d99cc, sha256 8d86275b427f2b4c809f64e230e66084da4cde922e23485edd00e7d0b4531161)
BibTeX
@misc{dc66dbc29d99cc,
  title = {A Pilot Study of Salmon Protein Hydrolysate (ProGo®) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health — Europe PMC PMID:42652046},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42652046},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_66dbc29d99cc; sha256 8d86275b427f2b4c809f64e230e66084da4cde922e23485edd00e7d0b4531161},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652046. Agents can read the archived copy with the MCP tool read_document.